Scinai Immunotherapeutics (FRA:2F50) E10: €-1,328.29 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2F50 Scinai Immunotherapeutics Ltd FRA:2F50
20 GF Score
Price €2.26
! 4 Warning Signs
View Full Analysis

What is Scinai Immunotherapeutics E10?

Scinai Immunotherapeutics FRA:2F50 20 E10 is €-1,328.29 as of Mar. 2026. GuruFocus rates FRA:2F50 with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Scinai Immunotherapeutics's adjusted earnings per share data for the three months ended in Mar. 2026 was €8.171. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1,328.29 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-26), Scinai Immunotherapeutics's current stock price is €2.26. Scinai Immunotherapeutics's E10 for the quarter that ended in Mar. 2026 was €-1,328.29. Scinai Immunotherapeutics's Shiller PE Ratio of today is .


Scinai Immunotherapeutics  (FRA:2F50) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Scinai Immunotherapeutics E10 Related Terms


Scinai Immunotherapeutics E10 Historical Data

* Premium members only.

The historical data trend for Scinai Immunotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinai Immunotherapeutics E10 Chart

Scinai Immunotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1,726.69 -1,523.25 0.00

Scinai Immunotherapeutics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,523.25 -1,525.34 -3,471.82 0.00 -1,328.29

FRA:2F50 vs ABPO, RMTG, EVFM: E10 Comparison

For the Biotechnology subindustry, Scinai Immunotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinai Immunotherapeutics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scinai Immunotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Scinai Immunotherapeutics's Shiller PE Ratio falls into.


FRA:2F50
20GF Score
Scinai Immunotherapeutics Ltd FRA:2F50
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinai Immunotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinai Immunotherapeutics's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.171/330.2130*330.2130
=8.171

Current CPI (Mar. 2026) = 330.2130.

Scinai Immunotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201603 -95.012 238.132 -131.751
201606 -184.650 241.018 -252.985
201609 -189.854 241.428 -259.673
201612 -185.065 241.432 -253.118
201703 -722.542 243.801 -978.637
201706 -714.507 244.955 -963.195
201709 95.079 246.819 127.204
201712 -504.134 246.524 -675.275
201803 -461.896 249.554 -611.187
201806 -935.985 251.989 -1,226.539
201809 -94.890 252.439 -124.125
201812 -1,616.907 251.233 -2,125.213
201903 19.515 254.202 25.350
201906 -1,782.951 256.143 -2,298.535
201909 -521.319 256.759 -670.459
201912 -1,053.809 256.974 -1,354.150
202003 -101.385 258.115 -129.704
202006 -1,030.378 257.797 -1,319.814
202009 984.825 260.280 1,249.431
202012 -292.954 260.474 -371.389
202103 -201.249 264.877 -250.890
202106 -305.917 271.696 -371.804
202109 -211.177 274.310 -254.214
202112 -158.319 278.802 -187.513
202203 -108.960 287.504 -125.146
202206 -151.360 296.311 -168.678
202209 404.000 296.808 449.469
202212 -339.840 296.797 -378.102
202303 -112.080 301.836 -122.617
202306 -110.760 305.109 -119.873
202309 74.960 307.789 80.421
202312 -73.360 306.746 -78.972
202403 -36.800 312.332 -38.907
202406 -37.160 314.175 -39.057
202409 75.684 315.301 79.263
202412 -78.662 315.605 -82.303
202503 -7.464 319.799 -7.707
202506 -27.684 322.561 -28.341
202512 0.000 324.054 0.000
202603 8.171 330.213 8.171

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1,328.29 mean?
Scinai Immunotherapeutics (FRA:2F50) has a E10 of €-1,328.29 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors.
Is Scinai Immunotherapeutics' E10 too high?
Scinai Immunotherapeutics' current E10 is €-1,328.29. Overall, Scinai Immunotherapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scinai Immunotherapeutics' E10 compare to ABPO and RMTG?
Scinai Immunotherapeutics' E10 of €-1,328.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors. Scinai Immunotherapeutics's current E10 is €-1,328.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinai Immunotherapeutics stock overvalued right now?
Scinai Immunotherapeutics (FRA:2F50) has a current E10 of €-1,328.29. The current E10 is €-1,328.29. Scinai Immunotherapeutics' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Scinai Immunotherapeutics (FRA:2F50), the current E10 is €-1,328.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scinai Immunotherapeutics Business Description

Other Exchanges SCNI:USA
Address Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
20GF Score

Get the complete analysis for FRA:2F50

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.26
Price